<DOC>
	<DOCNO>NCT02806531</DOCNO>
	<brief_summary>This phase IV clinical study evaluate safety enterovirus 71 vaccine child age 6-35 month old method passive active surveillance .</brief_summary>
	<brief_title>Safety Study Enterovirus 71 Vaccine Children Aged 6-35 Months Old</brief_title>
	<detailed_description />
	<mesh_term>Enterovirus Infections</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<criteria>Infant toddler age 6 35 month , meet criterion receive vaccine base judgement caregiver vaccination clinic . And The legal guardian willing vaccination expense . History allergy vaccine ingredient gentamycin ; Fever , acute disease , acute stage chronic disease ; Having serious chronic disease , allergic constitution ; Refusal followup safety concern .</criteria>
	<gender>All</gender>
	<minimum_age>6 Months</minimum_age>
	<maximum_age>35 Months</maximum_age>
	<verification_date>June 2016</verification_date>
	<keyword>vaccine</keyword>
	<keyword>safety</keyword>
</DOC>